<code id='D48A9B3C11'></code><style id='D48A9B3C11'></style>
    • <acronym id='D48A9B3C11'></acronym>
      <center id='D48A9B3C11'><center id='D48A9B3C11'><tfoot id='D48A9B3C11'></tfoot></center><abbr id='D48A9B3C11'><dir id='D48A9B3C11'><tfoot id='D48A9B3C11'></tfoot><noframes id='D48A9B3C11'>

    • <optgroup id='D48A9B3C11'><strike id='D48A9B3C11'><sup id='D48A9B3C11'></sup></strike><code id='D48A9B3C11'></code></optgroup>
        1. <b id='D48A9B3C11'><label id='D48A9B3C11'><select id='D48A9B3C11'><dt id='D48A9B3C11'><span id='D48A9B3C11'></span></dt></select></label></b><u id='D48A9B3C11'></u>
          <i id='D48A9B3C11'><strike id='D48A9B3C11'><tt id='D48A9B3C11'><pre id='D48A9B3C11'></pre></tt></strike></i>

          Home / hotspot / hotspot

          hotspot


          hotspot

          author:leisure time    Page View:2233
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In